NEWS
Among recent notices: Lifetime achievement award for Dr. Ron Weinstein; and Dr. Sam Keim elected to American Board of Emergency Medicine.
At 7,541 administered from Nov. 9-13, the university’s COVID-19 testing, which continues through Nov. 25, is succeeding in goal to test large numbers of students before they head home for holidays.
The university will expand in-person instruction with half the semester left to go, bringing about 1,500 more students to campus a week.
Researchers are expanding research showing that creating good sleeping habits can help people quit smoking to focus on smokers who are HIV positive.
The university remains in stage two of its reentry plan this week, with classes of up to 50 students given the option to meet on campus.
The University of Arizona has licensed new radio-labeling chemistry for PET contrast agents to startup TheraCea Pharma.
The university is currently allowing courses of up to 50 students to meet on campus. After Thanksgiving, all courses will transition to being fully online.
The contribution will allow UArizona researchers to continue developing better, more efficient and effective tests for people across the state.
In pre-clinical studies, researchers found that low-dose ketamine infusions can improve pain, depression and levodopa-induced dyskinesia in Parkinson's patients.
Give yourself the gift of good health! The University of Arizona Health Sciences is offering an uplifting program to improve health and reduce stress.
Researchers in the College of Pharmacy say compounds targeting proteins involved in viral replication may further drug development for treating COVID-19.
University of Arizona Department of Urology faculty member Dr. Sunchin Kim and general urology nurse practitioner Cara Whittingham will provide patient care at the Cortaro Road Banner clinic in Tucson.
Dr. Donna D. Zhang’s research focuses on developing pharmaceuticals to prevent or treat exposure to arsenic, which has affected more than 160 million people worldwide.
The tele-ultrasound training program for lung point-of-care ultrasound (POCUS) will enable rural emergency departments to more effectively identify and treat suspected COVID-19 patients.
Two faculty members inducted to National Academy of Inventors, ‘Gut Group’ team wins $250,000 for gastrointestinal cancer research, Dr. Chalasani wins NCI team leadership award, and new physicians join as pediatrics, infectious disease specialists.
The Arizona portion of an 11-state effort, funded by a $12 million federal award, to address the uneven impact of the pandemic on racial and ethnic minority communities will be led by the UArizona Health Sciences.
Researchers developed one of the most accurate COVID-19 antibody tests available and now have shown antibodies persist for months after infection, providing long-term immunity.
The $2.3 million National Institutes of Health grant will enable Dr. Alicia Allen to explore how women’s hormones influence postpartum opioid relapse and if they may be used as a preventative strategy.